Surgical therapy
Surgical access to facilitate mechanical instrumentation of the
roots has been utilized to treat chronic periodontitis for dec-
ades. A surgical approach to the treatment of periodontitis is
utilized in an attempt to: 1) provide better access for removal
of etiologic factors; 2) reduce deep probing depths; and 3) re-
generate or reconstruct lost periodontal tissues.
96-98
Clinical trials indicate that both surgical and nonsurgical
approaches can be effective in achieving stability of clinical
attachment levels.
60-65,99-103
Flap reflection is capable, however,
of increasing the efficacy of root debridement, especially at
sites with deep probing depths or furcations.
60-65,70,72,99-104
Nevertheless, complete calculus removal, even with surgi-
cal access, may not always be achieved.
70,72,104
The addition of
osseous resection during surgical procedures appears to produce
greater reduction of probing depth due to gingival reces-
sion,
62,64,65
particularly in furcations.
66
Regardless of the type of
therapy, furcated teeth are problematic since they are still more
likely to lose clinical attachment than nonfurcated teeth.
66,67,105
While these overall findings are helpful, the practitioner
should base specific decisions for therapy on findings for each
individual patient.
Regenerative surgical therapy
The optimal goal of therapy for individuals who have lost a
significant amount of periodontal attachment is regeneration
of lost tissues. While root debridement in combination with
plaque control has demonstrated efficacy in resolving inflam-
mation and arresting periodontitis,
26,27,60-65
healing typically
results in the formation of a long junctional epithelium
106-108
with remodeling of the alveolus.
109
Similarly, surgical debride-
ment alone does not induce significant amounts of new
connective tissue attachment.
110,111
However, some bone fill
may occur in selected sites.
107,112
Clinical trials suggest that obtaining new periodontal
attachment or regenerating lost tissues is enhanced by the
use of adjunctive surgical technique devices and materials.
Chemical agents that modify the root surface, while promoting
new attachment, have shown variable results when used in
humans.
113-118
Bone grafting
119-125
and guided tissue regeneration
(GTR) techniques, with or without bone replacement grafts,
126-133
may be successful when used at selected sites with advanced
attachment loss. The use of biologically engineered tissue induc-
tive proteins (eg, growth factors, extracellular matrix proteins,
and bone morphogenic proteins) to stimulate periodontal or
osseous regeneration has also shown promise.
134-142
Literature
reviews on periodontal regeneration
143,144
and mucogingival
therapy
145
provide additional information regarding these
therapies.
Regenerative therapy and other treatment modalities can
be affected by several risk factors (eg, diabetes and tobacco
use) which can diminish periodontal treatment outcomes.
146
In
this regard, cigarette smoking is associated with a high risk for
progressive periodontitis
9-13,147
and treatment for periodontitis
may be less effective in smokers than non-smokers.
148-150
These
factors are reviewed in more depth in the Academy’s position
paper Tobacco Use and the Periodontal Patient.
151
To maximize
effective prevention and treatment of periodontitis, patients
should be encouraged to stop smoking and to stop using
smokeless tobacco.
Occlusal management
Several studies indicated that excessive occlusal forces do not
initiate plaque-induced periodontal disease or connective tissue
attachment loss (periodontitis).
152-155
However, other investiga-
tions suggest that tooth mobility may be associated with adverse
effects on the periodontium and affect the response to therapy
with respect to gaining clinical attachment.
156,157
With regards to
treatment, occlusal therapy may aid in reducing tooth mobility
and gaining some bone lost due to traumatic occlusal forces.
158
Occlusal equilibration also may be used to ameliorate a variety
of clinical problems related to occlusal instability and restorative
needs.
159
Clinicians should use their judgment as to whether
or not to perform an occlusal adjustment as a component of
periodontal therapy based upon an evaluation of clinical fac-
tors related to patient comfort, health and function.
160
370 ENDORSEMENTS
REFERENCE MANUAL V 37
/
NO 6 15
/
16
Periodontal maintenance procedures
Periodic monitoring of periodontal status and appropriate
maintenance procedures should be part of the long-term
treatment plan for managing chronic periodontitis.
28
Although
experimental studies have demonstrated very successful treat-
ment outcomes when patients are professionally maintained
at two-week intervals,
161
such a program is impractical for
most chronic periodontitis patients. Therefore, to maximize suc-
cessful therapeutic outcomes, patients must maintain effective
daily plaque control. It also appears that in-office periodontal
maintenance at three to four month intervals can be effective
in maintaining most patients.
4
A more comprehensive review
on this subject can be found in the American Academy of
Periodontology’s position paper entitled Supportive Periodontal
Therapy (SPT).
162
Summary
The inflammatory components of plaque induced gingivitis
and chronic periodontitis can be managed effectively for the
majority of patients with a plaque control program and non-
surgical and/or surgical root debridement coupled with con-
tinued periodontal maintenance procedures. Some patients
may need additional therapeutic procedures. All of the
therapeutic modalities reviewed in this position paper may be
utilized by the clinician at various times over the long-term
management of the patient’s periodontal condition.
References
1. American Academy of Periodontology. The pathogen-
esis of periodontal diseases (position paper). J Periodontol
1999;70:457-70.
2. American Academy of Periodontology. Diagnosis of
Periodontal Diseases (position paper). Chicago, Ill: The
American Academy of Periodontology; April 1995.
3. Armitage GC. Development of a classification system
for periodontal diseases and conditions. Ann Periodontol
1999;4:1-6.
4. Ramfjord SP. Maintenance care and supportive perio-
dontal therapy. Quintessence Int 1993;24:465-71.
5. Page RC. Gingivitis. J Clin Periodontol 1986;13:345-59.
6. Ranney RR, Debski BF, Tew JG. Pathogenesis of gingi-
vitis and periodontal disease in children and young
adults. Pediatr Dent 1981;3:89-100.
7. Socransky SS, Haffajee AD. Microbial mechanisms in the
pathogenesis of destructive periodontal diseases: A critical
assessment. J Periodont Res 1991;26:195-212.
8. Wolff L, Dahlen G, Aeppli D. Bacteria as risk markers
for periodontitis. J Periodontol 1994;65:498-510.
9. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk
for periodontal disease. I. Risk indicators for attachment
loss. J Periodontol 1994;65:260-7.
10. Grossi SG, Genco RJ, Machtei EE, et al. Assessment of
risk for periodontal disease. II. Risk indicators for alveolar
bone loss. J Periodontol 1995;66:23-9.
11. Ismail A, Morrison E, Burt B, Caffesse R, Kavanaugh MT.
Natural history of periodontal disease in adults: Findings
from the Tecumseh Periodontal Disease Study, 1959-
1987. J Dent Res 1990;69:430-5.
12. Haber J, Wattles J, Crowley M, Mandell R, Joshipurak K,
Kent RL. Evidence for cigarette smoking as a major risk
factor for periodontitis. J Periodontol 1993;64:16-23.
13. Bergstrom J, Preber H. Tobacco use as a risk factor. J
Periodontol 1994;65:545-50.
14. Oliver RC, Tervonen T. Diabetes: A risk factor for perio-
dontitis in adults? J Periodontol 1994;65:530-8.
15. Michalowicz BS. Genetic and heritable risk factors in
periodontal disease. J Periodontol 1994;65:479-88.
16. Löe H, Theilade E, Jensen SB. Experimental gingivitis in
man. J Periodontol 1965;36:177-87.
17. Theilade E, Wright WH, Jensen SB, Löe H. Experimental
gingivitis in man. II. A longitudinal clinical and bacterio-
logical investigation. J Periodont Res 1966;1:1-13.
18. Lindhe J, Axelsson P. The effect of a preventive program-
me on dental plaque, gingivitis, and caries in school chil-
dren. Results after one and two years. J Clin Periodontol
1974;1:126-38.
19. Suomi JD, Greene JC, Vermillion JR, Doyle J, Chang JJ,
Leatherwood EC. The effect of controlled oral hygiene
procedures on the progression of periodontal disease in
adults: Results after third and final year. J Periodontol
1971;42:152-60.
20. Axelsson P, Lindhe J. Effect of controlled oral hygiene
procedures on caries and periodontal disease in adults.
Results after 6 years. J Clin Periodontol 1981;8:239-48.
21. De la Rosa M, Guerra JZ, Johnston DA, Radike AW.
Plaque growth and removal with daily toothbrushing. J
Periodontol 1979;50:661-4.
22. MacGregor IDM, Rugg-Gunn AJ, Gordon PH. Plaque
levels in relation to the number of toothbrushing strokes
in uninstructed English schoolchildren. J Periodont Res
1986;21:577-82.
23. Lang NP, Cumming BR, Löe H. Toothbrushing fre-
quency as it relates to plaque development and gingival
health. J Periodontol 1973;44:396-405.
24. Listgarten MA, Schifter CC, Laster L. 3-year longitudinal
study of the periodontal status of an adult population
with gingivitis. J Clin Periodontol 1985;12:225-38.
25. Agerbaek N, Melsen B, Lind OP, Glavind L, Kristiansen
B. Effect of regular small group instruction per se on
oral health status of Danish schoolchildren. Community
Dent Oral Epidemiol 1979;7:17-20.
26. Tagge DL, O’Leary TJ, El-Kafrawy AH. The clinical
and histological response of periodontal pockets to root
planing and oral hygiene. J Periodontol 1975;46:527-33.
27. Lövdal A, Arno A, Schei O, Waerhaug J. Combined effect
of subgingival scaling and controlled oral hygiene on
the incidence of gingivitis. Acta Odontol Scand 1961;19:
537-55.
28. Hancock EB. Prevention. Ann Periodontol 1996;1:223-49.
AMERICAN ACADEMY OF PEDIATRIC DENTISTRY
ENDORSEMENTS 371
29. Mandel ID. Antimicrobial mouthrinses: Overview and
update. J Am Dent Assoc 1994;125(suppl 2):2S-10S.
30. Brecx M, Brownstone E, MacDonald L, Gelskey S, Cheang
M. Efficacy of Listerine, Meridol, and chlorhexidine as
supplements to regular tooth-cleaning measures. J Clin
Periodontol 1992;19:202-7.
31. Pitcher GR, Newman HN, Strahan JD. Access to subgingival
plaque by disclosing agents using mouthrinsing and direct
irrigation. J Clin Periodontol 1980;7:300-8.
32. American Academy of Periodontology. The role of supra-
and subgingival irrigation in the treatment of periodontal
diseases (position paper). Chicago, Ill: The American
Academy of Periodontology; April 1995.
33. Mealey BL. Periodontal implications: Medically compro-
mised patients. Ann Periodontol 1996;1:293-303.
34. Drinkard CR, Decher L, Little JW, et al. Periodontal status
of individuals in early stages of human immunodeficiency
virus infection. Community Dent Oral Epidemiol 1991;
19:281-5.
35. Friedman RB, Gunsolley J, Gentry A, Dinius A, Kaplowitz
L, Settle J. Periodontal status of HIV seropositive and
AIDS patients. J Periodontol 1991;62:623-7.
36. Riley C, London JP, Burmeister JA. Periodontal health in
200 HIV-positive patients. J Oral Pathol Med 1992;21:
124-7.
37. Masouredis CM, Katz MH, Greenspan D, et al. Prevalence
of HIV-associated periodontitis and gingivitis in
HIV-infected patients attending an AIDS clinic. J Acquir
Immune Defic Syndr 1992;5:479-83.
38. Glick M, Muzyka BC, Salkin LM, Lurie D. Necrotizing
ulcerative periodontitis: A marker for immune deterior-
ation and a predictor for the diagnosis of AIDS. J
Periodontol 1994;65:393-7.
39. American Academy of Periodontology. Periodontal consi-
derations in the HIV-positive patient (position paper).
Chicago, Ill: The American Academy of Periodontology;
April 1994.
40. Tomar SL, Swango PA, Kleinman DV, Burt BA. Loss
of periodontal attachment in HIV-seropositive military
personnel. J Periodontol 1995;66:421-8.
41. Redding SW, Montgomery MT. Acyclovir prophylaxis for
oral herpes simplex infection in patients with bone marrow
transplants. Oral Surg Oral Med Oral Pathol 1989;67:680-3.
42. Hassell TM, Hefti AF. Drug induced gingival over-
growth: Old problem, new problem. Crit Rev Oral Biol
Med 1991;2:103-37.
43. Butler RT, Kalkwarf KL, Kaldahl WB. Drug-induced
gingival hyperplasia: Phenytoin, cyclosporine, and
nifedipine. J Am Dent Assoc 1987;114:56-60.
44. Miller CS, Damm DD. Incidence of verapamil-induced
gingival hyperplasia in a dental population. J Periodontol
1992;63:453-6.
45. Nery EB, Edson RG, Lee KK, Pruthi VK, Watson J.
Prevalence of nifedipine-induced gingival hyperplasia. J
Periodontol 1995;66:572-8.
46. Mealey BL. Periodontal implications: Medically compro-
mised patients. Ann Periodontol 1996;1:303-8.
47. Pihlstrom B. Prevention and treatment of dilantin asso-
ciated gingival enlargement. Compendium Continuing
Educ Dent 1990;11(suppl 14):S506-S510.
48. Hall WB. Dilantin hyperplasia: A preventable lesion?
Compendium Continuing Educ Dent 1990;11(suppl 14):
S502-5.
49. Jones JE, Weddell JA, McKown CG. Incidence and indi-
cations for surgical management of phenytoin-induced
gingival overgrowth in a cerebral palsy population. J Oral
Maxillofac Surg 1998;46:385-90.
50. Hall EE. Prevention and treatment considerations in pa-
tients with drug-induced gingival enlargement. Curr
Opin Periodontol 1997;4:59-63.
51. Ilgenli T, Atilla G, Baylas H. Effectiveness of periodon-
tal therapy in patients with drug-induced gingival over-
growth. Long-term results. J Periodontol 1999;70:967-72.
52. Morrison EC, Ramfjord SP, Hill RW. Short-term effects
of initial, nonsurgical periodontal treatment (hygienic
phase). J Clin Periodontol 1980;7:199-211.
53. Garrett JS. Effects of nonsurgical periodontal therapy on
periodontitis in humans. A review. J Clin Periodontol 1983;
10:515-23.
54. Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical
periodontal therapy. I. Moderately advanced periodont-
itis. J Clin Periodontol 1981;8:57-72.
55. Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical
periodontal therapy. II. Severely advanced periodontitis. J
Clin Periodontol 1984;11:63-76.
56. Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical
periodontal therapy. III. Single versus repeated instru-
mentation. J Clin Periodontol 1984;11:114-24.
57. Hughes TP, Caffesse RG. Gingival changes following scaling,
root planing and oral hygiene - A biometric evaluation. J
Periodontol 1978;49:245-52.
58. Magnusson I, Lindhe J, Yoneyama T, Liljenberg B.
Recolonization of subgingival microbiota following scaling
in deep pockets. J Clin Periodontol 1984;11:193-207.
59. Mosques T, Listgarten MA, Phillips RW. Effect of scaling
and root planing on the composition of the human sub-
gingival microbial flora. J Periodont Res 1980;15:144-51.
60. Pihlstrom BL, McHugh RB, Oliphant TH, Ortiz-Campos
C. Comparison of surgical and nonsurgical treatment of
periodontal disease. A review of current studies and ad-
ditional results after 6-1/2 years. J Clin Periodontol 1983;
10:524-44.
61. Hill RW, Ramfjord SP, Morrison EC, et al. Four types of
periodontal treatment compared over two years. J Perio-
dontol 1981;52:655-62.
62. Kaldahl WB, Kalkwarf KL, Patil KD, Dyer JK, Bates RE
Jr. Evaluation of four modalities of periodontal therapy.
Mean probing depth, probing attachment level, and reces-
sion changes. J Periodontol 1988;59:783-93.
372 ENDORSEMENTS
REFERENCE MANUAL V 37
/
NO 6 15
/
16
63. Becker W, Becker BE, Ochsenbein C, et al. A longitudinal
study comparing scaling, osseous surgery, and modified
Widman procedures. Results after one year. J Periodontol
1988;59:351-65.
64. Ramfjord SP, Caffesse RG, Morrison EC, et al. 4 modalities
of periodontal treatment compared over 5 years. J Clin
Periodontol 1987;14:445-52.
65. Kaldahl WB, Kalkwarf KL, Kashinath D, Patil D, Molvar
MP, Dyer JK. Long-term evaluation of periodontal therapy:
I. Response to 4 therapeutic modalities. J Periodontol
1996;67:93-102.
66. Kalkwarf KL, Kaldahl WB, Patil KD. Evaluation of fur-
cation region response to periodontal therapy. J Perio-
dontol 1988;59:794-804.
67. Kaldahl WB, Kalkwarf KL, Kashinath D, Patil D, Molvar
MP, Dyer JK. Long-term evaluation of periodontal
therapy: II. Incidence of sites breaking down. J Periodontol
1996;67:103-8.
68. Ainslie P, Caffesse R. A biometric evaluation of gingival
curettage (II). Quintessence Int 1981;6:609-14.
69. Echeverra JJ, Caffesse RG. Effects of gingival curettage
when performed 1 month after root instrumentation. A
biometric evaluation. J Clin Periodontol 1983;10:277-86.
70. Caffesse RG, Sweeney PL, Smith BA. Scaling and root
planing with and without periodontal flap surgery. J Clin
Periodontol 1986;13:205-10.
71. Rabbani GM, Ash MM, Caffesse RG. The effectiveness of
subgingival scaling and root planing in calculus removal. J
Periodontol 1981;52:119-23.
72. Fleischer HC, Mellonig JT, Brayer WK, Gray JL, Barnett
JD. Scaling and root planing efficacy in multirooted
teeth. J Periodontol 1989;60:402-9.
73. Drisko CH. Non-surgical pocket therapy: Pharmaco-
therapeutics. Ann Periodontol 1996;1:491-566.
74. Magnusson I, Low SB, McArthur WP, et al. Treatment
of subjects with refractory periodontal disease. J Clin
Periodontol 1994;21:628-37.
75. van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological
and clinical results of metronidazole plus amoxicillin ther-
apy in Actinobacillus actinomycetemomitans-associated
periodontitis. J Periodontol 1992;63:52-7.
76. Magnusson I, Clark WB, Low SB, Maruniak J, Marks RG,
Walker CB. Effect of non-surgical periodontal therapy
combined with adjunctive antibiotics in subjects with
“refractory” periodontal disease. I. Clinical results. J Clin
Periodontol 1989;16:647-53.
77. Kornman KS, Robertson PB. Clinical and microbio-
logical evaluation of therapy for juvenile periodontitis. J
Periodontol 1985;56:443-6.
78. Williams R, Jeffcoat M, Howell T, et al. Altering the pro-
gression of human alveolar bone loss with the non-steroidal
anti-inflammatory drug flurbiprofen. J Periodontol
1989;60:485-90.
79. Williams RC, Jeffcoat MK, Howell TH, et al. Ibuprofen:
An inhibitor of alveolar bone resorption in beagles. J
Periodont Res 1988;23:225-9.
80. Howell TH, Jeffcoat MK, Goldhaber P, et al. Inhibition of
alveolar bone loss in beagles with the NSAID naproxen. J
Periodont Res 1991;26:498-501.
81. Crout RJ, Lee HM, Schroeder H, et al. The “cyclic” regimen
of low-dose doxycycline for adult periodontitis: A pre-
liminary study. J Periodontol 1996;67:506-14.
82. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treat-
ment with subantimicrobial doses of doxycycline: Effects
on gingival fluid collagenase activity and attachment loss
in adult periodontitis. J Clin Periodontol 2001;28:146-56.
83. Caton J. Evaluation of Periostat for patient management.
Compend Continuing Educ Dent 1999;20:451-62.
84. Caton J, Ciancio SG, Bleiden TM, et al. Treatment with
subantimicrobial dose doxycycline improves the efficacy
of scaling and root planing in patients with adult peri-
odontitis. J Periodontol 2000;71:521-32.
85. Walker CB. The acquisition of antibiotic resistance in the
periodontal microflora. Periodontol 2000 1996;10:79-88.
86. Goodson JM, Cugini MA, Kent RL, et al. Multicenter
evaluation of tetracycline fiber therapy: II. Clinical response.
J Periodont Res 1991;26:371-9.
87. American Academy of Periodontology. The role of con-
trolled drug delivery for periodontitis (position paper). J
Periodontol 2000;71:125-40.
88. Goodson JM, Tanner A, McArdle S, Dix K, Watanabe SM.
Multicenter evaluation of tetracycline fiber therapy: III.
Microbiological response. J Periodont Res 1991;26:440-51.
89. Drisko CH, Cobb CM, Killoy WJ, et al. Evaluation of
periodontal treatments using controlled release tetracycline
fibers: Clinical response. J Periodontol 1995;66:692-9.
90. Michalowicz BS, Pihlstrom BL, Drisko CH, et al. Evaluation
of periodontal treatments using controlledrelease tetracy- Dostları ilə paylaş: |